In closing its therapeutics division and laying off 200 people, 23andMe ended an audacious bet it made nearly a decade ago — ...

In weakly acid conditions, lipid A can be hydrolyzed to obtain monophosphoryl lipid A (MPL® [GSK and other]), a compound ... Here we describe cancer vaccine candidates using MPL adjuvant in ...

Pro forma cash and investment balance of $683.9 million as of September 30, 2024 expected to provide runway through 2027 across a number of impactful portfolio milestones. WATER ...

The company and other pharma groups that have sold ranitidine products over the ... can cause several forms of cancer and other illnesses – which is disputed by GSK and other defendants, which ...

GSK and other pharma companies that have sold ranitidine products over the years have ... evidence that ranitidine increases the risk of any cancer,” adding: “There are 16 epidemiological ...

Royalty Pharma inaugural Prize for Impact in Healthcare awarded to Michael Milken, the founder of the Milken Institute, Faster Cures & the ...

Astrazeneca is set to report earnings next week after a turbulant few months for the FTSE 100 firm and its China arm.

AstraZeneca has become the latest big pharma company to devote new cash to its US manufacturing muscle this year as it ...

The winner will be announced Wednesday evening at The American Lawyer's Industry Awards. These attorneys have been named ...

Cancer Center at Froedtert Hospital. This milestone... at 13:00 Ojjaara (momelotinib) approved in Canada for the treatment of myelofibrosis in adults who have moderate to severe anemia GSK announced ...